"We are excited to expand our technology to be able to capture not only circulating cancer cells from solid tumor and blood cancers but also now to begin to isolate cfDNA and exosomes, as well," said Rolf Muller, BioFluidica's CEO. "We can now employ all important biomarkers on one single liquid biopsy platform, our programmable microfluidic chips. This will have very positive outcomes for personalized medicine in the cancer diagnostics space as we commercialize further, as well as for researchers and patients."
This research is supported by the National Cancer Institute of the National Institutes of Health under Award Numbers R43CA232848 and 1R43CA228923-01A1.
Willing to Take the Health Risk. Of 1000 women surveyed:
- 1 in 3 use tanning beds and will continue to despite health risks
- 91% are aware of the health risks
- Almost half (48%) say sunbeds are addictive
Beyond a Tan. The Perceived Benefits by...
XRP Healthcare, a pioneering force in healthcare innovation, proudly announces the registration of its trademark in Uganda, marking a significant milestone in its commitment to revolutionize healthcare services in the region. Concurrently, the...
On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated in Harbin, Heilongjiang province, China, marking a significant advance in the province's efforts to address public...
Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its financial results from the first quarter 2024. Almirall delivered strong sales growth in the first quarter of 2024 which continues to be driven by the...
AnX Robotica, the leader in advanced gastrointestinal visualization technologies, is happy to announce a recent publication validating the clinical benefits of using ProScan, the first FDA cleared AI Assisted Reading Tool for Small Bowel Video...
The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from May 31 to June 4, 2024. As the largest and most academically prestigious international oncology conference in the world, the ASCO Annual Meeting gathers...